Expanding the Orbit of Primary Prevention - Moving beyond JUPITER.

[1] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J]. LANCET, 2005, 366 (9493) : 1267 - 1278

[2] Early stopping of randomized clinical trials for overt efficacy is problematic [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (03) : 241 - 246

[3] Cholesterol Treatment Trialists' (CTT) Collaborators, 2008, LANCET, V371, P2084

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497

[5] A sustained mortality benefit from screening for abdominal aortic aneurysm (vol 146, pg 699, 2007) [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (03) : 216 - 216

[6] A sustained mortality benefit from screening for abdominal aortic aneurysm [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (10) : 699 - 706

[7] Routine vs selective invasive strategies in patients with acute coronary syndromes - A collaborative meta-analysis of randomized trials [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (23): : 2908 - 2917

[8] Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial [J]. LANCET, 2006, 368 (9552) : 2053 - 2060

[9] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J]. CIRCULATION, 2003, 107 (03) : 499 - 511

[10] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) : 2195 - 2207

[1] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J]. LANCET, 2005, 366 (9493) : 1267 - 1278

[2] Early stopping of randomized clinical trials for overt efficacy is problematic [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (03) : 241 - 246

[3] Cholesterol Treatment Trialists' (CTT) Collaborators, 2008, LANCET, V371, P2084

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497

[5] A sustained mortality benefit from screening for abdominal aortic aneurysm (vol 146, pg 699, 2007) [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (03) : 216 - 216

[6] A sustained mortality benefit from screening for abdominal aortic aneurysm [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (10) : 699 - 706

[7] Routine vs selective invasive strategies in patients with acute coronary syndromes - A collaborative meta-analysis of randomized trials [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (23): : 2908 - 2917

[8] Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial [J]. LANCET, 2006, 368 (9552) : 2053 - 2060

[9] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J]. CIRCULATION, 2003, 107 (03) : 499 - 511

[10] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) : 2195 - 2207